Sharepoint Solutions
PRODUCTS
-
The most widely trusted solution for clinical trial disclosure management
Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.
Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.
-
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
-
When applied to plant influents, hydrogen peroxide destroys dissolved and/or total sulfide that otherwise scavenges Fe3+ added for CEPT and/or chemical phosphorus removal from wastewater. The foundational aspect of this PRI-TECH application (called PRI-CEPT) is that one lb of total sulfide theoretically consumes 3.5 lbs Fe3+ and thus represents an additional cost of $2 – 3 per lb influent sulfide.
-
Become compliant with FDA 21 CFR Part 11 and EudraLex Annex 11 software validation
SoftMax® Pro 7.2 GxP Software is the latest, most secure software to achieve full FDA 21 CFR Part 11 and EudraLex Annex 11 compliance with streamlined workflows to ensure data integrity. Every step is optimized to simplify analysis and reporting to support our microplate readers.
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
WHITE PAPERS AND CASE STUDIES
-
Applying A Platform Approach To Bispecific Antibody Development
Explore how experts were able to adjust a mAb production and purification platform to be applicable for the rapid development and scale up of a BsAb.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials
This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.
-
The Role Of The Technical Transfer Executive Sponsor
Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.
-
Avoiding The Pitfalls Of PQR
Explore the fundamentals of Product Quality Reviews (PQRs), common challenges manufacturers face, strategies for streamlining PQRs, and solutions that aim to unlock the potential of a "real-time PQR."
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
AqueoUS Vets Named A Manufacturing Partner For A Southern CA Water Treatment Facility
In August 2018, Aqueous Vets was selected over existing industry incumbents to supply the Granular Activated Carbon Systems (GACS) for a Southern California Water Treatment Plant.
-
Selecting A New Sporicidal Disinfectant: What The Cleanroom Manager Needs To Know
This guide helps cleanroom managers evaluate sporicides by efficacy, safety, and compatibility to ensure contamination control without compromising operational integrity.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
NEWS
-
Avance Clinical Expands Specialist CNS, Cardiometabolic, And Rare Diseases CRO Services In Europe With Julius Clinical5/28/2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.
-
Klarna Announces Partnership With OnePay To Exclusively Power Installment Loans At Walmart In The U.S3/17/2025
Klarna, the AI-powered payments and commerce network, today announced that it will be partnering with OnePay, a leading consumer finance app, to exclusively offer installment loans for purchases at Walmart in the United States.
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
New Antibiotic Class Effective Against Multidrug-Resistant Bacteria4/1/2024
Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The new antibiotic class is described in an article in the scientific journal PNAS.
-
Biden-Harris Administration Announces $16.5M For US Virgin Islands Water Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/20/2024
Today, the US Environmental Protection Agency (EPA) announced over $16.5M from President Biden's Investing in America agenda for US Virgin Islands drinking water and clean water infrastructure upgrades.